🔗 Share this article

Chancellor Reeves has announced she is planning "specific action to deal with household expense challenges" in next month's financial statement.

Speaking to media outlets, she stated that curbing price rises is a joint task of both the administration and the central bank.

The United Kingdom's inflation rate is projected to be the most elevated among the Group of Seven advanced economies this year and next.

Possible Energy Cost Interventions

Sources suggest the administration could take action to bring down energy bills, for example by reducing the current 5% rate of VAT charged on energy supplies.

A further possibility is to cut some of the regulatory levies currently added to household expenses.

Budgetary Constraints and Analyst Predictions

The government will receive the next report from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will clarify how much space there is for these measures.

The consensus from the majority of analysts is that the Chancellor will have to declare higher taxes or budget cuts in order to fulfill her voluntary fiscal targets.

Previously on the same day, analysis showed there was a twenty-two billion pound deficit for the Treasury chief to fill, which is at the more modest range of projections.

"There's a joint responsibility between the central bank and the administration to bear down further on some of the sources of inflation," the Chancellor stated to the BBC in Washington, at the annual meetings of the International Monetary Fund and global financial institution.

Tax Pledges and International Concerns

While much of the focus has been on expected tax increases, the chancellor said the latest figures from the OBR had not altered her commitment to manifesto promises not to increase tax levels on earnings tax, sales tax or National Insurance.

She attributed an "uncertain global environment" with increasing international and commercial tensions for the Budget revenue measures, probably to be focused on those "with the broadest shoulders."

Global Trade Disputes

Commenting on apprehensions about the United Kingdom's commercial links with the Asian nation she said: "The UK's security interests always take priority."

Recent announcement by China to tighten export controls on critical minerals and other materials that are crucial for advanced tech production led US President Donald Trump to suggest an extra 100% tariff on imports from China, increasing the risk of an full-scale trade war between the two economic giants.

The US Treasury Secretary called the Chinese action "commercial pressure" and "a international production power grab."

Questioned on accepting the US offer to participate in its battle with the Asian nation, Reeves said she was "very concerned" by China's measures and urged the Beijing authorities "not to put up barriers and restrict access."

She said the move was "harmful for the world economy and creates additional challenges."

"It is my opinion there are fields where we should address Chinese policies, but there are also significant prospects to sell into China's economy, including financial services and other areas of the economy. We've got to get that balance right."

The chancellor also confirmed she was working with G7 counterparts "on our own critical minerals strategy, so that we are more independent."

Health Service Medicine Pricing and Funding

Reeves also acknowledged that the cost the National Health Service spends on pharmaceuticals could go up as a consequence of ongoing discussions with the US government and its pharmaceutical firms, in return for reduced taxes and funding.

A number of the world's largest pharmaceutical manufacturers have said lately that they are either halting or canceling operations in the United Kingdom, with some blaming the low prices they are getting.

Last month, the Science Minister said the cost the health service spends on medicines would need to increase to stop businesses and drug research funding leaving the United Kingdom.

The Chancellor informed the BBC: "We have seen because of the cost structure, that clinical trials, recent pharmaceuticals have not been provided in the United Kingdom in the extent that they are in other European countries."

"The objective is to guarantee that patients receiving treatment from the NHS are able to obtain the finest life-saving medicines in the globe. And so we are reviewing these issues, and... aiming to attract increased capital into the UK."